- Vince Wacher, PhD
Chief Executive Officer
- Dr. Vince Wacher was CEO of Adipogen Pharmaceuticals Pty Ltd prior to the merger of Autogen and Adipogen. Vince has 18 years experience leading applied research; clinical trials; product development; intellectual property (registered US patent agent); corporate strategy; joint venture; and business development programs for start-ups, small pharma and new business units within large companies. He received an Eastman Business Builder Award in 2004 for his work with Eastman Chemical Company (a Fortune 500 company) in advancing their drug delivery/specialty pharma programs. Vince was awarded the University Medal in Chemistry from the University of NSW, Australia (1988) and received a scholarship to complete his PhD at the University of California, Berkeley (1988-92). He then undertook post-doctoral studies with Professor Leslie Benet at the University of California, San Francisco (1992-94), where he published some of the first papers describing the overlap between P-gp and CYP3A. He currently divides his time between Australia and California.